Domain 5 of Beta 2 glycoprotein I: Friend or foe in health? Context matters

被引:0
|
作者
Giannakopoulos, Bill [1 ,2 ]
Krilis, Steven A. [1 ,3 ]
机构
[1] Univ New South Wales, Fac Med & Hlth, St George & Sutherland Campus,Level 2,Pitney Bldg,, Sydney, NSW 2217, Australia
[2] St George Publ Hosp, Dept Rheumatol, Kogarah, Sydney 2217, Australia
[3] St George Publ Hosp, Dept Infect Dis Immunol & Sexual Hlth, Kogarah, Sydney 2217, Australia
关键词
Beta 2 glycoprotein I; Domain; 5; Antiphospholipid syndrome; Ischemia-reperfusion injury; Thrombosis; BETA(2)-GLYCOPROTEIN I; ANTIPHOSPHOLIPID SYNDROME; GLYCOPROTEIN-I; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; LIPID-BINDING; INHIBITOR; RECEPTOR; PLASMIN; ANGIOGENESIS;
D O I
10.1016/j.clim.2024.110282
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Beta 2 glycoprotein I ((32GPI) is the major autoantigen in the antiphospholipid syndrome, an autoimmune disorder characterized by thrombotic and obstetric complications. The autoantibodies that target beta 2 glycoprotein I are pathogenic and contribute to disease pathogenesis. The (32GPI molecule is composed of 5 domains that are numbered 1 through to 5. Autoantibodies bind mainly to domain 1 whereas the majority of the biological functions of the (32GPI molecule in diverse processes such as apoptotic cell clearance, complement regulation, lipopolysaccharide clearance and anticoagulation have been localised to domain 5 and its unique biochemistry, reviewed in this article. The role of purified domain 5 peptide as a potential therapeutic agent in APS and ischemia reperfusion injury is discussed.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS
    Thomas McDonnell
    Charis Pericleous
    Emmanuelle Laurine
    Rita Tommasi
    Acely Garza-Garcia
    Ian Giles
    Yiannis Ioannou
    Anisur Rahman
    BMC Biotechnology, 15
  • [32] Domain I of beta2-glycoprotein I: A potentially important diagnostic and therapeutic antigenic target for the antiphospholipid syndrome
    Ioannou, Y.
    Pericleous, C.
    Latchman, D. S.
    Isenberg, D. A.
    Rahman, A.
    RHEUMATOLOGY, 2006, 45 : I16 - I16
  • [33] ANTI-BETA2 GLYCOPROTEIN I DOMAIN I ANTIBODIES: A PREDICTIVE VALUE FOR THROMBOSIS? A SINGLE CENTRE EXPERIENCE
    Vilalta Seto, N.
    Llobet Lorente, D.
    Vallve Fornielles, C.
    Borrell Valls, M.
    Carrasco Exposito, M.
    Fontcuberta Boj, J.
    THROMBOSIS RESEARCH, 2014, 133 : S74 - S74
  • [34] Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS
    McDonnell, Thomas
    Pericleous, Charis
    Laurine, Emmanuelle
    Tommasi, Rita
    Garza-Garcia, Acely
    Giles, Ian
    Ioannou, Yiannis
    Rahman, Anisur
    BMC BIOTECHNOLOGY, 2015, 15
  • [35] New Tests to Detect Antiphospholipid Antibodies: Anti-Domain I Beta-2-Glycoprotein-I Antibodies
    Chighizola, Cecilia Beatrice
    Gerosa, Maria
    Meroni, Pier Luigi
    CURRENT RHEUMATOLOGY REPORTS, 2014, 16 (02)
  • [36] New Tests to Detect Antiphospholipid Antibodies: Anti-Domain I Beta-2-Glycoprotein-I Antibodies
    Cecilia Beatrice Chighizola
    Maria Gerosa
    Pier Luigi Meroni
    Current Rheumatology Reports, 2014, 16
  • [37] A novel, efficient, expression system of domain I of human beta2 glycoprotein I in E-coli
    Ioannou, Y
    Giles, I
    Lambrianides, N
    Latchman, DS
    Isenberg, DA
    Rahman, A
    RHEUMATOLOGY, 2005, 44 : I141 - I142
  • [38] PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
    Willis, Rohan
    McDonnell, Thomas C. R.
    Pericleous, Charis
    Gonzalez, Emilio B.
    Schleh, Alvaro
    Romay-Penabad, Zurina
    Giles, Ian P.
    Rahman, Anisur
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] Beta-2-glycoprotein I exerts antithrombotic function through its domain V in mice
    Passam, Freda H.
    Chen, Gang
    Chen, Vivien M.
    Qi, Miao
    Krilis, Steven A.
    Giannakopoulos, Bill
    JOURNAL OF AUTOIMMUNITY, 2022, 126
  • [40] A PHOSPHOLIPID-BINDING SITE AND A REGION RECOGNIZED BY ANTICARDIOLIPIN ANTIBODIES IS LOCATED IN THE 5TH DOMAIN OF BETA-2-GLYCOPROTEIN-I
    HUNT, J
    KRILIS, S
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, : 76 - 76